X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (462) 462
Publication (70) 70
Book Chapter (8) 8
Book / eBook (6) 6
Patent (5) 5
Conference Proceeding (2) 2
Magazine Article (2) 2
Book Review (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (241) 241
female (182) 182
index medicus (159) 159
cancer (138) 138
oncology (135) 135
breast cancer (120) 120
breast neoplasms - pathology (87) 87
life sciences (87) 87
middle aged (80) 80
immunohistochemistry (76) 76
pathology (72) 72
prognosis (68) 68
adult (61) 61
aged (57) 57
breast neoplasms - drug therapy (51) 51
breast neoplasms - genetics (50) 50
[ sdv.can ] life sciences [q-bio]/cancer (46) 46
chemotherapy (39) 39
tumors (39) 39
male (37) 37
her2 (36) 36
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
biomarkers, tumor - analysis (31) 31
research (31) 31
trastuzumab (31) 31
[sdv.can]life sciences [q-bio]/cancer (29) 29
aged, 80 and over (28) 28
antineoplastic agents - therapeutic use (27) 27
breast neoplasms - metabolism (27) 27
expression (27) 27
gene expression (27) 27
therapy (27) 27
treatment outcome (27) 27
in-situ hybridization (26) 26
carcinoma (25) 25
genetics & heredity (25) 25
neoplasm staging (25) 25
analysis (24) 24
breast neoplasms - chemistry (24) 24
care and treatment (24) 24
survival (24) 24
animals (23) 23
breast neoplasms - diagnosis (23) 23
disease-free survival (23) 23
gene amplification (22) 22
mutation (22) 22
retrospective studies (22) 22
skin and connective tissue diseases (22) 22
antibodies, monoclonal, humanized (21) 21
in situ hybridization (21) 21
neoadjuvant therapy (21) 21
receptor, erbb-2 - genetics (21) 21
biomarkers (20) 20
breast (20) 20
cell biology (20) 20
cell line, tumor (20) 20
medicine (20) 20
cetuximab (19) 19
chemotherapy, adjuvant (19) 19
france (19) 19
genetic aspects (19) 19
receptor, erbb-2 - metabolism (19) 19
adjuvant chemotherapy (18) 18
antibodies, monoclonal - therapeutic use (18) 18
breast neoplasms - surgery (18) 18
diagnosis (18) 18
egfr (18) 18
immunohistochemistry - methods (18) 18
in situ hybridization, fluorescence (18) 18
neoadjuvant chemotherapy (18) 18
receptor, erbb-2 - analysis (18) 18
lymphatic metastasis (17) 17
medicine & public health (17) 17
breast neoplasms - therapy (16) 16
gene expression regulation, neoplastic (16) 16
guidelines (16) 16
hematology, oncology and palliative medicine (16) 16
induction chemotherapy (16) 16
biochemistry, molecular biology (15) 15
biopsy (15) 15
breast neoplasms - mortality (15) 15
genes (15) 15
metastasis (15) 15
molecular biology (15) 15
ovarian neoplasms - pathology (15) 15
prospective studies (15) 15
receptor, epidermal growth factor - metabolism (15) 15
research article (15) 15
amplification (14) 14
biomarkers, tumor - genetics (14) 14
immunotherapy (14) 14
mice (14) 14
predictive value of tests (14) 14
risk factors (14) 14
surgery (14) 14
biomarkers, tumor - metabolism (13) 13
cells (13) 13
epidermal growth factor (13) 13
estrogen (13) 13
genetics (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2012, Volume 132, Issue 3, pp. 895 - 915
Journal Article
Nature Medicine, ISSN 1078-8956, 05/2017, Volume 23, Issue 5, pp. 568 - 578
Chromosomal instability (CIN), a feature of most adult neoplasms from their early stages onward, is a driver of tumorigenesis. However, several malignancy... 
MOLECULAR CHARACTERIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATED PROTEIN-KINASE | CYCLIN-E | INSTABILITY | PROBE LEVEL DATA | DNA-DAMAGE RESPONSE | HUMAN-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMOR | ONCOGENE-INDUCED SENESCENCE | CELL BIOLOGY | EPITHELIAL-MESENCHYMAL TRANSITION | Epithelial Cells - metabolism | Reactive Oxygen Species | Tissue Array Analysis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Immunoblotting | Gene Expression Profiling | Stem Cells - cytology | Methionine Sulfoxide Reductases - genetics | Stem Cells - metabolism | Zinc Finger E-box-Binding Homeobox 1 - genetics | Tumor Suppressor Protein p53 - genetics | Zinc Finger E-box-Binding Homeobox 1 - metabolism | Breast Neoplasms - metabolism | Young Adult | Cell Differentiation - genetics | Flow Cytometry | Chromatin Immunoprecipitation | Cell Transformation, Neoplastic - genetics | Aged, 80 and over | Adult | Female | Epithelial Cells - cytology | Real-Time Polymerase Chain Reaction | Genomic Instability - genetics | Mammary Glands, Human - cytology | Tumor Suppressor Protein p53 - metabolism | Sequence Analysis, DNA | Methionine Sulfoxide Reductases - metabolism | Animals | Breast Neoplasms - genetics | Adolescent | Fluorescent Antibody Technique | Cell Line, Tumor | Carcinoma - genetics | Mice, Inbred NOD | Aged | Carcinoma - metabolism | DNA Damage | Life Sciences | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2009, Volume 27, Issue 30, pp. 5068 - 5074
Journal Article
Nature medicine, ISSN 1078-8956, 11/2014, Volume 20, Issue 11, pp. 1301 - 1309
Some of the anti-neoplastic effects of anthracyclines in mice originate from the induction of innate and T cell-mediated anticancer immune responses. Here we... 
MEDICINE, RESEARCH & EXPERIMENTAL | DOUBLE-STRANDED-RNA | DENDRITIC CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | INNATE | RIG-I | TUMORS | CELL BIOLOGY | TOLL-LIKE RECEPTOR-3 | BREAST-CANCER | ANTICANCER CHEMOTHERAPY | GENE | IMMUNE-RESPONSES | Doxorubicin - therapeutic use | Breast Neoplasms - immunology | Humans | RNA, Messenger - metabolism | Adaptor Proteins, Vesicular Transport - metabolism | Interferon Type I - biosynthesis | Receptors, Pattern Recognition - metabolism | Neoplasm Metastasis | Anthracyclines - pharmacology | Interferon Type I - metabolism | Female | Neoadjuvant Therapy | Gene Expression Regulation, Neoplastic - drug effects | RNA - metabolism | Receptor, Interferon alpha-beta - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Treatment Outcome | Toll-Like Receptor 3 - metabolism | Breast Neoplasms - drug therapy | Animals | Breast Neoplasms - genetics | Signal Transduction - drug effects | Breast Neoplasms - pathology | Immunocompetence - drug effects | Anthracyclines - therapeutic use | Chemokine CXCL10 - metabolism | Myxovirus Resistance Proteins - metabolism | Doxorubicin - pharmacology | Anthracyclines | Care and treatment | Analysis | Physiological aspects | Interferon | Research | Cancer | Signal transduction | Chemotherapy | Breast cancer | Chemokines | Life Sciences | Immunology | Immunotherapy
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2005, Volume 11, Issue 14, pp. 5175 - 5180
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2013, Volume 13, Issue 1, pp. 351 - 351
Journal Article
Modern Pathology, ISSN 0893-3952, 10/2016, Volume 29, Issue 10, pp. 1155 - 1164
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 5803 - 5803
Journal Article
Journal Article